← FDA Drug Approvals (Drugs@FDA)

SUNLENCA

NDA · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2022-12-22

Drug application

FDA Application #

NDA215973

Application type

New Drug Application

Brand name

SUNLENCA

Generic name

LENACAPAVIR SODIUM

Active ingredients

LENACAPAVIR SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

GILEAD SCIENCES INC

Manufacturer

Gilead Sciences, Inc.

First approval

2022-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown